PURPOSE: Summary scores derived from the medical outcomes study HIV health survey (MOS-HIV) are used to assess treatment impacts among HIV-infected patients in Western settings, but have yet to be validated in rural, African settings. We examined the reliability, validity and responsiveness of scores among a prospective cohort of 947 HIV-1-infected adults initiating antiretroviral therapy between May 2003 and May 2004 in rural Uganda. METHODS: Physical (PHS) and mental health (MHS) summary scores were developed from baseline MOS-HIV sub-domains using exploratory factor analysis. Construct and discriminant validity were established by comparing mean summary scores across known groups of sociodemographic, clinical and health status characteristics. Effect sizes were calculated to assess responsiveness to therapy. RESULTS: Reliability of the PHS and MHS scores was 0.79 and 0.85, respectively. Mean baseline PHS and MHS scores varied significantly by CD4 cell count, HIV viral load, WHO stage of disease and Karnofsky performance status scores. By 12 months on antiretroviral therapy, PHS and MHS scores improved by 14.6 points (P < 0.001) and 13.9 points (P < 0.001), respectively. CONCLUSIONS: PHS and MHS scores can be derived from the MOS-HIV and used to assess health status among cohorts of patients taking antiretroviral therapy in rural Uganda.
PURPOSE: Summary scores derived from the medical outcomes study HIV health survey (MOS-HIV) are used to assess treatment impacts among HIV-infectedpatients in Western settings, but have yet to be validated in rural, African settings. We examined the reliability, validity and responsiveness of scores among a prospective cohort of 947 HIV-1-infected adults initiating antiretroviral therapy between May 2003 and May 2004 in rural Uganda. METHODS: Physical (PHS) and mental health (MHS) summary scores were developed from baseline MOS-HIV sub-domains using exploratory factor analysis. Construct and discriminant validity were established by comparing mean summary scores across known groups of sociodemographic, clinical and health status characteristics. Effect sizes were calculated to assess responsiveness to therapy. RESULTS: Reliability of the PHS and MHS scores was 0.79 and 0.85, respectively. Mean baseline PHS and MHS scores varied significantly by CD4 cell count, HIV viral load, WHO stage of disease and Karnofsky performance status scores. By 12 months on antiretroviral therapy, PHS and MHS scores improved by 14.6 points (P < 0.001) and 13.9 points (P < 0.001), respectively. CONCLUSIONS: PHS and MHS scores can be derived from the MOS-HIV and used to assess health status among cohorts of patients taking antiretroviral therapy in rural Uganda.
Authors: Rebecca Bunnell; John Paul Ekwaru; Peter Solberg; Nafuna Wamai; Winnie Bikaako-Kajura; Willy Were; Alex Coutinho; Cheryl Liechty; Elizabeth Madraa; George Rutherford; Jonathan Mermin Journal: AIDS Date: 2006-01-02 Impact factor: 4.177
Authors: Patrick M Tarwater; Joel E Gallant; John W Mellors; Mary E Gore; John P Phair; Roger Detels; Joseph B Margolick; Alvaro Muñoz Journal: AIDS Date: 2004-12-03 Impact factor: 4.177
Authors: A W Wu; H R Rubin; W C Mathews; J E Ware; L T Brysk; W D Hardy; S A Bozzette; S A Spector; D D Richman Journal: Med Care Date: 1991-08 Impact factor: 2.983
Authors: Christina Psaros; Jessica E Haberer; Yap Boum; Alexander C Tsai; Jeffrey N Martin; Peter W Hunt; David R Bangsberg; Steven A Safren Journal: AIDS Behav Date: 2015-01
Authors: Alexander C Tsai; William R Wolfe; Elias Kumbakumba; Annet Kawuma; Peter W Hunt; Jeffrey N Martin; David R Bangsberg; Sheri D Weiser Journal: J Interpers Violence Date: 2015-01-13
Authors: Kathryn J Fiorella; Erin M Milner; Charles R Salmen; Matthew D Hickey; Dan O Omollo; Abdi Odhiambo; Brian Mattah; Elizabeth A Bukusi; Lia C H Fernald; Justin S Brashares Journal: Proc Natl Acad Sci U S A Date: 2017-04-04 Impact factor: 11.205
Authors: Judith A Hahn; Nneka I Emenyonu; Robin Fatch; Winnie R Muyindike; Allen Kekiibina; Adam W Carrico; Sarah Woolf-King; Stephen Shiboski Journal: Addiction Date: 2015-11-05 Impact factor: 6.526
Authors: A E Ezeamama; D Guwatudde; M Wang; D Bagenda; K Brown; R Kyeyune; Emily Smith; H Wamani; Y C Manabe; W W Fawzi Journal: J Behav Med Date: 2016-01-05
Authors: Flora Cohen; Sabrina Hermosilla; Justin Knox; Gary Samuel Agaba; Grace Obalim; Rehema Kajungu; Patrick Onyango Mangen; Lindsay Stark Journal: BMC Public Health Date: 2021-05-17 Impact factor: 3.295
Authors: Becky L Genberg; Juddy Wachira; Jon A Steingrimsson; Sonak Pastakia; Dan N Tina Tran; Jamil AbdulKadir Said; Paula Braitstein; Joseph W Hogan; Rajesh Vedanthan; Suzanne Goodrich; Catherine Kafu; Marta Wilson-Barthes; Omar Galárraga Journal: BMJ Open Date: 2021-05-18 Impact factor: 3.006